Genmab — Februar 2016
-
Tak MUFC - man kunne da også høre på CC, at de selv mente deres guidance var i den lave ende, men hvad skal de ellers gøre. Mon ikke også der er en realistisk chance for at få en godkendelse på baggrund af Pollux i slutningen af året (gerne lige inden ASH for max effekt).
-
Novod mener at Darzalex/Pomalyst kombo kan generere positiv trigger. I forbindelse med publicering i vigtigt medicinalt tidskrift. Som nævnt af Jan på cc. Når denne publicering foreligger, så kan læger begynde at anbefale behandling, og der gives tilskud fra sygekasser. Kan vist komme snart
-
Fornuftig start på dagen.

-
Åbenbart ikke, ellers ville det vel være sket
-
"Pomalyst combination based on highly impressive phase II data"
-
Nordea expect this combo also to get NCCN inclusion
-
Winkel nævnte offentliggørelse i vigtigt tidsskrift på cc
-
https://oasm.finanstilsynet.dk/dk/soegeresultat.aspx?t=genmab Noget af forklaringen på salgspresset
-
https://www.deshaw.com/FirmManagement.shtml Det er så disse her der har shortet omkring 300.000 stk aktier.
-
Dr. Shaw was appointed to the President’s Council of Advisors on Science and Technology by President Clinton in 1994, and again by President Obama in 2009. He is a two-time winner of the ACM Gordon Bell Prize, and was elected to the American Academy of Arts and Sciences in 2007, to the National Academy of Engineering in 2012, and to the National Academy of Sciences in 2014.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind